CPHI

China Pharma Holdings, Inc. CPHI

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CPHI FLGC ENSC RDHL SNOA AMIX TTNP OGEN KALA XBIO
6M -31.89 % -73.30 % -61.02 % -43.80 % -8.10 % -71.31 % -49.02 % -33.57 % -88.69 % -34.53 %
YTD 4.13 % -4.09 % -10.44 % 32.04 % -9.62 % -11.86 % 27.87 % 13.77 % 8.68 % 12.37 %
1Y -40.00 % -82.45 % -89.16 % -75.89 % 24.15 % -84.92 % -28.66 % -88.77 % -90.69 % -43.02 %
3Y -97.68 % -96.34 % -99.35 % -99.29 % -87.81 % -99.53 % -87.14 % -99.63 % -96.59 % -43.68 %
5Y -99.64 % -99.82 % -100.00 % -99.98 % -98.01 % -99.53 % -96.31 % -99.94 % -99.82 % -91.25 %
10Y -98.22 % -99.82 % -100.00 % -99.99 % -99.58 % -99.53 % -99.98 % -99.99 % -99.93 % -99.61 %
From the beginning -99.99 % -99.82 % -100.00 % -99.99 % -99.99 % -99.53 % -100.00 % -100.00 % -99.93 % -99.61 %

Dividend